Didier Lebrec

TL;DR: It is concluded that continuous administration of propranolol by mouth is effective in preventing recurrent gastrointestinal bleeding in patients with cirrhosis.

TL;DR: In patients with alcoholic cirrhosis, the degree of portal hypertension has no predictive value for the risk of gastrointestinal bleeding and large-sized esophageal varices are associated with a high risk of occurrence or recurrence of gastrointestinal bleed and could be taken into account for a better selection of patients for portacaval shunt.

TL;DR: The prevalence of pulmonary hypertension in 507 patients hospitalized with portal hypertension but without known pulmonary hypertension who underwent cardiac catheterization was prospectively studied and no significant relation was found between elevated pulmonary vascular resistance and increased portal pressure, zzygos blood flow, or cardiac index.

TL;DR: In this paper, the authors analyzed data on individual patients from four randomized, controlled trials to assess the efficacy of the beta-adrenergic-antagonist drug therapy for the prevention of initial episodes of gastrointestinal bleeding.

TL;DR: In patients with type 1 HRS, terlipressin-induced improved renal function is associated with an increase in survival, and a randomized trial investigating the effect of ter Lipressin on survival in patients with types 1 and 2 HRS should be performed.